Reuptake

Results: 1360



#Item
201Abnormal psychology / Selective serotonin reuptake inhibitors / Sexual arousal / Sexual health / Mood disorders / Sexual dysfunction / Antidepressant / Female sexual arousal disorder / Bupropion / Psychiatry / Medicine / Chemistry

Urodinamica 14: 76-79, [removed]Urodinamica 14: 57-60, 2004) ©2004, Editrice Kurtis. Depression, antidepressants and female sexual

Add to Reading List

Source URL: www.afwh.org

Language: English
202Monoamine oxidase inhibitors / Amines / Euphoriants / Attention-deficit hyperactivity disorder / Dextropropoxyphene / Chromatography / Antidepressant / Selective serotonin reuptake inhibitor / Amphetamine / Chemistry / Medicine / Pharmacology

Thin Layer Chromatography The Thin Layer Chromatography assay detects over 300 drugs, including prescription and non-prescription drugs. A minimum of 10 mL of urine is required for this assay. Positive results for opiat

Add to Reading List

Source URL: protocols.sonichealthcare.com

Language: English - Date: 2014-04-08 19:21:50
203Bipolar disorder / Selective serotonin reuptake inhibitors / Abnormal psychology / Bipolar spectrum / Organochlorides / Antidepressant / Sertraline / Major depressive disorder / Venlafaxine / Psychiatry / Mood disorders / Emotion

Clinical Focus Primary Psychiatry. 2003;10(12):58-61 Gender, Depression, and Antidepressant Treatment Susan G. Kornstein, MD

Add to Reading List

Source URL: www.afwh.org

Language: English
204Pharmaceutical sciences / Atypical antipsychotics / Piperazines / Selective serotonin reuptake inhibitors / Healthcare reform in the United States / Food and Drug Administration / Off-label use / Boxed warning / Medicaid / Chemistry / Organic chemistry / Pharmacology

Second-Generation Antipsychotic Drug Use Among Medicaid-Enrolled Children: Quality-of-Care Concerns (OEI[removed]; 03/15).

Add to Reading List

Source URL: oig.hhs.gov

Language: English - Date: 2015-03-24 08:56:58
205Anxiety disorder / Anxiety / Major depressive disorder / Phobia / Antidepressant / Alcoholism / Cognitive behavioral therapy / Serotonin–norepinephrine–dopamine reuptake inhibitor / Mood disorder / Psychiatry / Abnormal psychology / Mental health

Parkinson’s disease, anxiety and depression Many people living with Parkinson’s disease also experience anxiety and/or depression. Anxiety and depression can result from

Add to Reading List

Source URL: www.parkinsonsvic.org.au

Language: English - Date: 2014-11-20 00:36:08
206Medicine / Serotonin / Selective serotonin reuptake inhibitors / Alcohols / Antidepressant / Amines / Serotonin syndrome / Paroxetine / Triptan / Chemistry / Organic chemistry / Pharmacology

DOC Document

Add to Reading List

Source URL: www.devonpartnership.nhs.uk

Language: English - Date: 2014-10-16 09:30:39
207Anxiety disorders / Selective serotonin reuptake inhibitors / Organofluorides / Amines / Abnormal psychology / Antidepressant / Venlafaxine / Paroxetine / Panic disorder / Psychiatry / Chemistry / Organic chemistry

Prescribing Guideline Pharmacological Treatment of Anxiety Spectrum and Related Disorders in Adults PG11

Add to Reading List

Source URL: www.devonpartnership.nhs.uk

Language: English - Date: 2014-06-24 05:31:50
208Amines / Organofluorides / Nitriles / Citalopram / Organochlorides / Sertraline / Antidepressant / Torsades de pointes / Chemistry / Organic chemistry / Selective serotonin reuptake inhibitors

DOC Document

Add to Reading List

Source URL: www.devonpartnership.nhs.uk

Language: English - Date: 2014-11-13 11:22:05
209Organochlorides / Organofluorides / Selective serotonin reuptake inhibitors / Antidepressants / Monoamine oxidase inhibitors / Venlafaxine / Moclobemide / Serotonin–norepinephrine reuptake inhibitor / Serotonin / Chemistry / Organic chemistry / Psychiatry

Special Considerations if Taking Azilect, Eldepryl, Selegiline or Selgene These medications must not be taken in combination Medication Interaction Pethidine

Add to Reading List

Source URL: www.parkinsonsvic.org.au

Language: English - Date: 2014-11-21 22:09:07
210Pharmaceutical Benefits Scheme / Pharmaceuticals policy / Pharmacology / Medical terms / Epidemiology / Newborn screening / Screening / Serotonin–norepinephrine–dopamine reuptake inhibitor / Medical prescription / Medicine / Health / Healthcare in Australia

PBAC STAKEHOLDER MEETING OUTCOME STATEMENT NITISINONE FOR TYROSINAEMIA TYPE 1 4 February 2015 Department of Health, Canberra Attendees Members of the Pharmaceutical Benefits Advisory Committee (PBAC), clinicians with

Add to Reading List

Source URL: pbs.gov.au

Language: English - Date: 2015-03-12 23:53:04
UPDATE